CANARY
Canary Medical Inc.
Application Filed: 2022-04-20
Trademark Application Details
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 97372322 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Kevin S. Costanza |
| Attorney Docket Number | 191166.229 |
Timeline
| 2022-04-20 | Application Filed |
| 2022-04-23 | Location: NEW APPLICATION PROCESSING |
| 2022-04-23 | Status: Live/Pending |
| 2022-04-23 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Canary Medical Inc. |
| Address | Suite 400 1450 Creekside Dr. Vancouver, BC CA V6J5B3 |
| Legal Entity Type | Corporation |
| Legal Entity State | CA |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| Type Code | Type |
|---|---|
| GS0101 | Angioplasty rings which measure blood flow, blood pressure and blood volume; artificial heart valves; Cardiovascular devices, namely, synthetic coronary stent grafts; coronary stents; implantable medical devices adapted for recording and transferring internal patient data and for monitoring the integrity and function of the device during use; Implants consisting of artificial materials; Joint prostheses; joint prostheses adapted for recording and transferring internal patient data and for monitoring the integrity and function of the implanted prosthesis during use; medical, surgical and orthopaedic implants made of artificial materials; medical, surgical, cardiovascular, neurovascular, pulmonary, spinal, aesthetic and orthopaedic implants, prostheses, components, devices, apparatus and instruments; medical devices, namely, medical sensors that are implanted or inserted into the human body used to continuously monitor the concentration of glucose in the human body and accessories therefor, namely, receivers, sensor housings and sensor insertion devices; medical devices, namely, medical sensors that are implanted or inserted into the human body used to continuously monitor bleeding in the human body and accessories therefor, namely, receivers, sensor housings and sensor insertion devices; Non-implantable and portable medical and diagnostic devices, namely, patient monitors and wearable patient monitor patches and ingestible patient sensors for monitoring, measuring and capturing physiologic data, environmental data, treatment data, data related to medications, pharmaceuticals, and supplements, and data transmitted by medical devices; medical devices, namely, wireless receivers and transmitters used for capturing patient physiologic data, patient environmental data, patient treatment data, data related to patient medications, pharmaceuticals, and supplements, and patient data transmitted by medical devices, ingestible sensors, implants, and conductive packaging and labels; Implantable medical devices, namely, patient monitors for monitoring and capturing physiologic data, environmental data, treatment data, data related to medications, pharmaceuticals, and supplements, and data transmitted by medical devices; orthopedic joint implants made of artificial materials; sensors specially adapted for use with medical devices for determining integrity, function and usage of integrated component parts in the nature of batteries and remote power sources, and also featuring a microcontroller, wireless transceiver, and memory electronics for use in recording and transferring internal patient data to a medical device external to the body comprised of a wireless transceiver, power source, microcontroller, and primary transceiver for communication with a medical implant; system consisting primarily of an artificial orthopedic implant, a wearable medical device, a charger for the wearable medical device, and computer hardware and software for providing kinematic data and information to medical professionals; systems for aneurism stent graph comprised primarily of medical sensors for measuring blood pressure, blood flow volume, and heart rate, stent graph leaks, and also featuring computer hardware and integrated software for communicating and transmitting sensor data; systems for hypertension monitoring comprised primarily of medical sensors for measuring blood pressure, blood flow volume, and heart rate, and also featuring computer hardware and integrated software for communicating and transmitting sensor data; systems for in vivo cardiovascular blood pressure monitoring comprised primarily of medical sensors for measuring blood pressure, blood flow volume, and heart rate, and also featuring computer hardware and integrated software for communicating and transmitting sensor data; systems specially adapted for use with medical devices for monitoring the integrity and function of a medical implant comprised primarily of sensors for determining battery integrity, life and usage, sensor and system integrity, life and usage, and medical implant integrity, functionality and usage, and also featuring computer hardware and integrated software for communicating and transmitting sensor data; wearable medical device |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2022-04-23 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2022-04-26 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2023-02-01 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2023-02-07 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2023-02-07 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2023-02-07 | 6 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2023-05-04 | 7 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2023-05-04 | 8 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2023-05-05 | 9 TEME I:Incoming Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2023-05-12 | 10 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2023-05-12 | 11 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2023-05-12 | 12 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2023-05-12 | 13 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2023-05-12 | 14 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2023-05-31 | 15 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2023-06-20 | 16 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2023-06-20 | 17 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2023-08-15 | 18 NOAM E:E-Mail |
| SOU TEAS EXTENSION RECEIVED | 2024-02-08 | 19 EEXT I:Incoming Correspondence |
| SOU EXTENSION 1 FILED | 2024-02-08 | 20 EXT1 S: |
| SOU EXTENSION 1 GRANTED | 2024-02-08 | 21 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2024-02-09 | 22 EXRA E:E-Mail |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 